Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,206 recalls · Class II, newest first

Class II · Moderate risk

Systane

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0429-15 D-1314-2022
Class II · Moderate risk

Naphcon A eye drops

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0085-15 D-1313-2022
Class II · Moderate risk

Bisacodyl Suppositories

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 57896-443-01 D-1312-2022
Class II · Moderate risk

Triple Antibiotic Ointment

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0498-0750-36 D-1311-2022
Class II · Moderate risk

Telmisartan and Hydrochlorothiazide Tablets USP

Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .

Terminated Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-841-13 D-1306-2022
Class II · Moderate risk

Telmisartan and Hydrochlorothiazide Tablets USP

Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .

Terminated Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-842-13 D-1305-2022
Class II · Moderate risk

Testosterone Gel 1%

Superpotent Drug: Out of specification assay result was obtained during stability testing.

Terminated Wrong potency / content Teva Pharmaceuticals USA Inc NDC 0591-3216-17 D-1289-2022
Class II · Moderate risk

Launch Sequence Capsules

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Terminated Unapproved drug Loud Muscle Science D-1339-2022
Class II · Moderate risk

Hydrogen Peroxide Topical Solution

Labeling: Label Mix-Up-The primary label on the front of the bottles have Hydrogen Peroxide affixed to the front and back of the containers. However, the product inside the bottle is 70% Isopropyl Alcohol.

Terminated Labeling / mix-up Vi-Jon, LLC NDC 59779-871-45 D-1191-2022

Recalls by year